0001209191-21-039422.txt : 20210610
0001209191-21-039422.hdr.sgml : 20210610
20210610153508
ACCESSION NUMBER: 0001209191-21-039422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210609
FILED AS OF DATE: 20210610
DATE AS OF CHANGE: 20210610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LILLY ENDOWMENT INC
CENTRAL INDEX KEY: 0000316011
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 211007966
BUSINESS ADDRESS:
STREET 1: 2801 NORTH MERIDIAN STREET
CITY: INDIANANAPOLIS
STATE: IN
ZIP: 46208
BUSINESS PHONE: 3179245471
MAIL ADDRESS:
STREET 1: 2801 NORTH MERIDIAN ST
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER COMPANY:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-09
0
0000059478
ELI LILLY & Co
LLY
0000316011
LILLY ENDOWMENT INC
2801 NORTH MERIDIAN STREET
INDIANAPOLIS
IN
46208-0068
0
0
1
0
Common Stock
2021-06-09
4
S
0
59848
223.903
D
109812252
D
Common Stock
2021-06-09
4
S
0
74766
224.934
D
109737486
D
Common Stock
2021-06-09
4
S
0
84516
225.635
D
109652970
D
Common Stock
2021-06-09
4
S
0
870
226.36
D
109652100
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.27 to $224.26, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.27 to $225.2681, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.27 to $226.26, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.3333 to $226.39, inclusive.
/s/Peter A. Buck, Vice President for Investments, on behalf of Lilly Endowment Inc.
2021-06-10